Delivery Order SPE2DB24D2018-SPE2DB25FWUJ6

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,404.98 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,654.11 contract is for the supply of 4,567,847,362 tablets of the prescription medication RINVOQ ER 30 MG. The order has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,334.98, is for the delivery of 4,567,926,729 units of the prescription medication RINVOQ ER 15 MG TABLET. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a $23,634.95 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,070,188 units of the medication RINVOQ ER 30 MG TABLET. The contract has an ultimate completion date of July 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RINVOQ ER 45 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The contract has a ceiling value of $154,552.32 and a period of performance through August 29, 2024. This appears to be a task order or delivery order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $37,078.52 delivery order contract is for the supply of RINVOQ ER 45 MG TABLET, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,410.75, is for the supply of 4,568,086,041 units of RINVOQ ER 15 MG TABLET with a completion date of May 1, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical...
This is a $7,149.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $26,769.11 and an ultimate completion date of April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a...
This is a $24,085.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication, with an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWUJ6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,091,888 units of the medication RINVOQ ER 45 MG TABLET, a rheumatoid arthritis treatment. The contract has a ceiling value of $27,243.18 and a period of performance through May 1, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely a part of that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:07 AM